Literature DB >> 10769487

Lassa fever imported to England.

.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10769487

Source DB:  PubMed          Journal:  Commun Dis Rep CDR Wkly        ISSN： 1350-9357


× No keyword cloud information.
  9 in total

1.  Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.

Authors:  P Pushko; J Geisbert; M Parker; P Jahrling; J Smith
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Design of peptide-based epitope vaccine and further binding site scrutiny led to groundswell in drug discovery against Lassa virus.

Authors:  Mohammad Uzzal Hossain; Taimur Md Omar; Arafat Rahman Oany; K M Kaderi Kibria; Abu Zaffar Shibly; Md Moniruzzaman; Syed Raju Ali; Md Monirul Islam
Journal:  3 Biotech       Date:  2018-01-16       Impact factor: 2.406

3.  Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR.

Authors:  Christian Drosten; Stephan Göttig; Stefan Schilling; Marcel Asper; Marcus Panning; Herbert Schmitz; Stephan Günther
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

4.  Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.

Authors:  Masayuki Saijo; Marie-Claude Georges-Courbot; Philippe Marianneau; Victor Romanowski; Shuetsu Fukushi; Tetsuya Mizutani; Alain-Jean Georges; Takeshi Kurata; Ichiro Kurane; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

5.  Pathogenesis of Lassa fever in cynomolgus macaques.

Authors:  Lisa E Hensley; Mark A Smith; Joan B Geisbert; Elizabeth A Fritz; Kathleen M Daddario-DiCaprio; Tom Larsen; Thomas W Geisbert
Journal:  Virol J       Date:  2011-05-06       Impact factor: 4.099

6.  Evaluation of Lassa antiviral compound ST-193 in a guinea pig model.

Authors:  Kathleen A Cashman; Mark A Smith; Nancy A Twenhafel; Ryan A Larson; Kevin F Jones; Robert D Allen; Dongcheng Dai; Jarasvech Chinsangaram; Tove' C Bolken; Dennis E Hruby; Sean M Amberg; Lisa E Hensley; Mary C Guttieri
Journal:  Antiviral Res       Date:  2011-03-01       Impact factor: 5.970

7.  Development of a new vaccine for the prevention of Lassa fever.

Authors:  Thomas W Geisbert; Steven Jones; Elizabeth A Fritz; Amy C Shurtleff; Joan B Geisbert; Ryan Liebscher; Allen Grolla; Ute Ströher; Lisa Fernando; Kathleen M Daddario; Mary C Guttieri; Bianca R Mothé; Tom Larsen; Lisa E Hensley; Peter B Jahrling; Heinz Feldmann
Journal:  PLoS Med       Date:  2005-06-28       Impact factor: 11.069

Review 8.  Mapping the zoonotic niche of Lassa fever in Africa.

Authors:  Adrian Q N Mylne; David M Pigott; Joshua Longbottom; Freya Shearer; Kirsten A Duda; Jane P Messina; Daniel J Weiss; Catherine L Moyes; Nick Golding; Simon I Hay
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-06-17       Impact factor: 2.184

Review 9.  Hemorrhagic fever viruses.

Authors:  David C Pigott
Journal:  Crit Care Clin       Date:  2005-10       Impact factor: 3.598
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.